The 56th edition of the European Diabetes Congress, organized by the EASD (European Association for the Study of Diabetes) from September 21 to 25, will be this virtual year. The virtual stand of WeHealth™ Digital Medicine reflects our commitment to the fight against diabetes
A complex and progressive disease, diabetes affects 463 million people worldwide and has caused the death of 4.2 million of them, that is 1 in 11 people*.
The aims of the EASD are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application.
What if new technologies could improve the diabetes practice of healthcare professionals?
WeHealth™ Digital Medicine is committed to the fight against diabetes and to working with healthcare professionals and diabetic patients for better management of the disease. During the first virtual EASD congress, WeHealth™ reaffirms its commitment through its 100% digital booth.
WeHealth™ Digital Medicine, is committed to its convictions of:
- Improving the patient journey
- Make prevention of patients affected by metabolic diseases a priority
- To improve the quality and experience of care for metabolic diseases through innovations in digital health care to provide life-changing solutions that address the unmet needs of people living with diabetes.
As a result, we are introducing a digital solution for diabetic patients:
DIET&YOU™: an application designed and developed with French startup DietSensor™ to help them manage the nutritional problems associated with their condition https://www.wehealth-digitalmedicine.com/en/products/dietyou
And a solution dedicated to healthcare professionals:
OLYATIS™: software solution developed with the French startup AISCREENINGS, which aims to facilitate the screening and management of patients suffering from diabetic retinopathy.
* Source: International Diabetes Federation, 2020.